Bluejay Diagnostics Inc. (NASDAQ: BJDX)
$0.57
-0.0005 ( -0.09% ) 318.4K
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
Market Data
Open
$0.57
Previous close
$0.57
Volume
318.4K
Market cap
$3.35M
Day range
$0.55 - $0.59
52 week range
$0.53 - $111.84
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
pre | Proxies and info statements | 3 | Jul 05, 2024 |
8-k | 8K-related | 21 | Jun 28, 2024 |
8-k | 8K-related | 16 | Jun 20, 2024 |
8-k | 8K-related | 16 | May 31, 2024 |
8-k | 8K-related | 14 | May 16, 2024 |
10-q | Quarterly Reports | 68 | May 15, 2024 |
def | Proxies and info statements | 3 | Apr 15, 2024 |
pre | Proxies and info statements | 3 | Apr 05, 2024 |
8-k | 8K-related | 14 | Apr 02, 2024 |
10-k | Annual reports | 78 | Mar 28, 2024 |